Viking Therapeutics Inc

25 set 2026, 20:02 UTC

Viking Therapeutics shares are lower amid volatility, despite positive trial data, as concerns over a recent capital raise and share sales at $35 persist.

24 set 2026, 20:03 UTC

Viking Therapeutics Inc. shares fell sharply after announcing a $500 million capital raise, including 7.86 million shares priced at $35.00 each, amid dilution concerns.

23 set 2026, 23:01 UTC

Viking Therapeutics plans to raise $400 million through stock and convertible notes offerings, causing significant after-hours trading decline amid dilution concerns.

22 set 2026, 23:01 UTC

Viking Therapeutics Inc gained after Oppenheimer raised its price target for VK2735 from $100 to $120, citing strong trial results and increased retail sentiment.

21 set 2026, 23:01 UTC

Viking Therapeutics Inc is advancing in after-market trading following notable social media interest, breaking a streak of ten consecutive lower daily closes.

18 set 2026, 20:07 UTC

Viking Therapeutics Inc is declining, continuing a downward trend as the broader market marks its tenth consecutive session of losses.

17 set 2026, 19:16 UTC

Viking Therapeutics Inc is trading higher as social media buzz surrounds VK2735 ahead of its anticipated Phase 3 trials, despite recent declines.

16 set 2026, 23:06 UTC

Viking Therapeutics Inc is trading modestly higher in after-market hours, following eight consecutive lower daily closes and recent broader market declines.

15 set 2026, 23:02 UTC

Viking Therapeutics Inc shares are higher during after-market hours, reflecting broader market trends despite recent economic indicators suggesting a slowdown in manufacturing.

14 set 2026, 19:36 UTC

Viking Therapeutics Inc shares are lower, continuing a trend of declines amid broader market weakness and rising crude oil prices affecting sentiment.

11 set 2026, 23:06 UTC

Viking Therapeutics Inc. shares are higher in after-market trading, despite routine fluctuations, and remain below their 20-day moving average.

10 set 2026, 20:07 UTC

Viking Therapeutics Inc shares are lower, influenced by a declining broader market and volatility in the biotech sector amid rising Treasury yields and inflation concerns.

9 set 2026, 23:11 UTC

Viking Therapeutics Inc shares are higher in after-market trading, recovering from earlier lows despite being below the 20-day moving average. No specific news was identified.

2 set 2026, 19:46 UTC

Viking Therapeutics Inc shares are lower today, pulling back from earlier session highs amid broader market concerns over rising U.S. Treasury yields.

31 ago 2026, 19:36 UTC

Viking Therapeutics shares are higher today, despite earlier pressure, amid broader market dynamics influenced by rising interest rate expectations following comments from the Fed.

29 ago 2026, 00:01 UTC

Viking Therapeutics Inc shares rose in after-market trading, reflecting a notable increase since Friday's close, despite no specific news driving the movement.

28 ago 2026, 23:36 UTC

Viking Therapeutics Inc. shares are higher in after-market trading, gaining since Friday's close, despite fluctuations and remaining below the 20-day moving average.

27 ago 2026, 23:02 UTC

Viking Therapeutics Inc shares are higher in after-market hours following notable volatility during the session, despite no specific news to explain the movement.

26 ago 2026, 19:16 UTC

Viking Therapeutics Inc shares are higher today, though no specific news was identified to explain the price movement. The stock remains above its 20-day moving average.

25 ago 2026, 23:16 UTC

Viking Therapeutics shares are lower in after-market hours amid broader market volatility, with falling oil prices and geopolitical developments affecting investor sentiment.

24 ago 2026, 19:56 UTC

Viking Therapeutics Inc shares are lower today, continuing a decline since Friday. Social media discussions highlight anticipation for upcoming data before Labor Day.

20 ago 2026, 20:06 UTC

Viking Therapeutics Inc shares are lower, impacted by labor market data and heightened volatility, despite social media discussions suggesting potential recovery from a clinical trial.

19 ago 2026, 23:16 UTC

Viking Therapeutics Inc shares are higher in after-market hours, reflecting a gain since Wednesday's close and remaining above the 20-day moving average.

18 ago 2026, 19:16 UTC

Viking Therapeutics Inc shares are lower today, with no specific news driving the decline amid rising U.S. Treasury yields affecting the biotechnology sector.

17 ago 2026, 23:06 UTC

Viking Therapeutics Inc shares are higher in after-market trading, reflecting unusual strength. No specific company news was identified to explain the price movement.

14 ago 2026, 23:06 UTC

Viking Therapeutics Inc shares are lower in after-market hours, trading at the lower end of their one-month range and below the 20-day moving average.

13 ago 2026, 23:16 UTC

Viking Therapeutics Inc shares are lower in after-market trading, with no specific news identified to explain the decline. The stock is near its one-month low.

12 ago 2026, 23:26 UTC

Viking Therapeutics Inc is trading lower in after-market hours, reflecting notable weakness with no specific news identified to explain the decline.

7 ago 2026, 19:36 UTC

Viking Therapeutics is rising amid broader market gains and anticipation of VK2809 trial results, with analysts noting potential for improved market position.

6 ago 2026, 23:16 UTC

Viking Therapeutics Inc gains in after-market hours amid discussions on pharmacokinetic modeling and anticipated VKTX maintenance readout results.